secwatch.observer — SEC 8-K summary
======================================

Issuer:     enGene Therapeutics Inc. (ENGN)
CIK:        0001980845
Form:       8-K
Filed at:   2025-06-04T23:59:59+00:00
Accession:  0000929638-25-002133
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

enGene CMO Dr. Raj Pruthi resigns; effective June 16, 2025
----------------------------------------------------------

- Dr. Raj Pruthi resigned as Chief Medical Officer; resignation date June 3, 2025.
- He will support orderly transition of responsibilities before leaving on June 16, 2025.
- No successor named; responsibilities reallocated to other urology and clinical experts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1980845/000092963825002133/0000929638-25-002133-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1980845/000092963825002133/a8k.htm
  HTML page:      https://secwatch.observer/filing/0000929638-25-002133

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer